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Laparoscopic liver resection is going to be a standard 
practice for straight forward cases. Laparoscopic has obvious 
advantages of rapid recovery and smaller wound. We are 
now entering an adaptation phase where more challenging 
indications and technically demanding procedures being 
ventured. It has been extended to laparoscopic procedures 
for pancreatic disease involving complex reconstructions, 
for liver cancer where patients had 
severe cirrhosis and combined resection for multiple 
organs.
Nearly 23% to 51% of the 157,000 new colorectal cancer 
patients will present with synchronous colorectal cancer 
and liver metastasis (1). Surgical resection of all tumor sites 
is the only treatment that offers prolonged survival (2-4). 
Minimally invasive approach for colorectal carcinoma 
has been an accepted treatment modality for many years. 
With improvement in surgical techniques, magnification 
of the camera and display unit, development of designated 
instrument, laparoscopic colorectal resection can be carried 
out safely, however, combined liver resection with colorectal 
cancer has still been considered as high risk operations with 
expected higher morbidity and even mortality. 
Ratti et al. recently reported totally laparoscopic 
combined management of  colorectal  cancer with 
synchronous hepatic metastases on severity of complications 
in the Surg Endosc (2016) (5). The authors showed that 
the totally laparoscopic method had lower blood loss (350 
vs. 600 mL), shorter postoperative stay (9 vs. 12 days), 
lower postoperative morbidity index (0.14 vs. 0.20), lower 
severity score for complicated patients (0.60 vs. 0.85), and 
better rapid functional recovery, had better recurrence- free 
survival. This study showed that simultaneous colorectal 
and hepatic resection can be safely performed as a one-
step procedure. The beauty of this result encourages the 
surgeons to perform totally laparoscopic surgery for primary 
colorectal cancer with synchronous liver metastases.
Since the World Consensus Conference on Laparoscopic 
Surgery has suggested that acceptable indications for 
laparoscopic liver resection include solitary lesions of 
5 cm or less, located in limited liver segments. Moreover, 
major hepatectomy (more than 3 segments) is reported to 
independently predict severe morbidity after simultaneous 
resection of CRC (hazard ratio =3.4, P=0.008). It is wise for 
Francesca’s group in carefully selecting patients with better 
risk to performed these combined laparoscopic resections 
(i.e., tumor size less than 5.0 cm, and up to 3 liver lesions).
“Doing no harm” is the most important concept of 
surgical treatment. Comparison of immediate outcome had 
been compared between one-step with two- step resection 
in various studies (6-9). Some studies have reported no 
difference in survival (6,8,9), whereas others reported that 
two-step resection results in better survival (10-12). These 
studies were small, retrospective, and subject to length-time 
bias and selection bias, potentially resulting in misleading 
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conclusions as to which procedure is better. In previous 
studies of simultaneous colorectal and hepatic resections, 
5-year survival rates ranged from 20% to 55%, with a 
median survival time of 28 to 40 months (12,13). Recently, 
Weber et al have shown that the median survival time and 
5-year survival rates of patients undergoing one-step liver 
resection were 35 months and 21%, respectively (8). They 
concluded that the characteristics of the primary tumor and 
the presence of synchronous colorectal and liver metastases 
had no influence on survival after one-step resection. The 
first question to consider with a synchronous versus staged 
resection for colorectal tumors with hepatic metastases 
is the safety of each approach. Vogt et al. was the first to 
examine the safety of synchronous resection for colorectal 
cancer (9). The authors compared operative mortality 
between 19 patients who underwent a synchronous resection 
to 17 patients who had a staged resection (median 2 months 
between resections). There were no perioperative deaths 
in either group. The authors concluded that synchronous 
resection was associated with a low rate of complication and 
no operative mortality provided that colorectal resections 
are not combined with extended liver resections. 
So I believed combined liver resection with colorectal 
cancer underwent laparoscopic procedure can be considered 
as a safety operation. 
The oncological outcomes of simultaneous colorectal 
and liver resections (SIMR) is vary in different published 
studies (14-17). The approach was suggested by some 
authors to be useful in selecting tumors with good biological 
behavior for the interval hepatic resection. But some 
authors believe that SIMR should not be totally excluded 
in the surgical management of CRM with its inherent 
advantage of complete macroscopic tumor clearance in one 
single operation and of facilitating timely commencement 
of adjuvant chemotherapy. Some studies have suggested 
that major hepatectomy would increase the short-term 
morbidity with SIMR (18,19) hence resulting in longer 
hospital stay.
However, patients requiring major liver resection should 
not be precluded from SIMR, provided that the meticulous 
operation is performed to ensure low short-term morbidity. 
Recent review also suggested SIMR should be undertaken 
in specialized colorectal and hepatobiliary surgery center in 
order to achieve better results (20).
In summary, the advantages of laparoscopy over open 
surgery have been highlighted in many series, both in 
the setting of isolated colorectal and in combination of 
hepatic resections. The current evidence is emerging but 
we still need a larger volume multicenter studies, preferably 
prospective design studies, to sustain the growth of this 
momentum.
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